Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA PK and Metabolomics in Healthy Elderly
NCT02789644Phase 1Unknown
- Sponsor
- Seoul National University Hospital
- Start
- May 2016
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ursodeoxycholic acid in primary biliary cholangitis (PBC) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Area under the plasma concentration-time curve at 24 hours. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02789644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789644.